Eli Lilly
LLY
817.63 supply$975.71K cap
$1,210.70
$37.41 · 3.09%
Info
Eli Lilly (LLY), the American drugmaker behind the obesity and diabetes injections Zepbound and Mounjaro, now the centre of its business, alongside cancer drugs, insulin and the Alzheimer's treatment Kisunla. It earns on patented prescription medicines, most of the money coming from the US market. Founded in Indianapolis in 1876, it was the first company to sell insulin commercially, in 1923. LLY on Robinhood Chain is a Robinhood Stock Token, a tokenised debt security issued by Robinhood Assets (Jersey) Limited and backed by Eli Lilly shares held in custody at Alpaca Securities.
Market Cap$975.71K
Circulating / Total Supply— / 817.63
Volume 24h$941.87K
$530.3K
$411.57K
